Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent

Condition:   Chronic Viral Hepatitis B With Delta-agent Interventions:   Drug: Myrcludex B;   Drug: PEG IFN alfa-2a Sponsor:   Hepatera Ltd. Active, not recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials